Mothaffar F. Rimawi

Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function

Suleiman Massarweh, C. Kent Osborne, Chad J. Creighton et al. · Cancer Research · 2008 · 491 citations

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

Lisa A. Carey, Hope S. Rugo, P. Kelly Marcom et al. · Journal of Clinical Oncology · 2012 · 489 citations · Full text

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

Xiaomei Zhang, Sofie Claerhout, Aleix Prat et al. · Cancer Research · 2013 · 470 citations · Full text

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Carey K. Anders et al. · Journal of Clinical Oncology · 2019 · 332 citations · Full text

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation

Yen-Chao Wang, Gladys Morrison, Ryan Gillihan et al. · Breast Cancer Research · 2011 · 282 citations · Full text